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In a clinical trial of a treatment for alcoholism, a common re-
sponse variable of interest is the number of alcoholic drinks consumed
by each subject each day, or an ordinal version of this response, with
levels corresponding to abstinence, light drinking and heavy drinking.
In these trials, within-subject drinking patterns are often character-
ized by alternating periods of heavy drinking and abstinence. For this
reason, many statistical models for time series that assume steady be-
havior over time and white noise errors do not fit alcohol data well.
In this paper we propose to describe subjects’ drinking behavior us-
ing Markov models and hidden Markov models (HMMs), which are
better suited to describe processes that make sudden, rather than
gradual, changes over time. We incorporate random effects into these
models using a hierarchical Bayes structure to account for correlated
responses within subjects over time, and we estimate the effects of
covariates, including a randomized treatment, on the outcome in a
novel way. We illustrate the models by fitting them to a large data set
from a clinical trial of the drug Naltrexone. The HMM, in particular,
fits this data well and also contains unique features that allow for
useful clinical interpretations of alcohol consumption behavior.
1. Introduction. A major goal in alcoholism research is to develop mod-
els that can accurately describe the drinking behavior of individuals with
Alcohol Use Disorders (AUDs: alcohol abuse or alcohol dependence), so as
to better understand common patterns among them. Clinical trials of treat-
ments for AUDs are run with the closely related goal of understanding the
relationship between a subject’s alcohol consumption and treatment vari-
ables, as well as certain background variables, like age and sex, and other
time-varying variables, like a daily measure of a subject’s desire to drink
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and/or stress level [McKay et al. (2006)]. It is of particular interest to un-
derstand the relationship between these variables and relapses into AUD,
as opposed to ordinary alcohol use. In summary, alcohol research is an area
in which statistical models are needed to provide rich descriptions of alco-
hol consumption as a stochastic process in such a way that we can make
inferences about the relationship between exogenous variables and drinking.
The main focus of this paper is developing models that are flexible enough to
describe a wide variety of drinking behaviors, and are parsimonious enough
to allow for clinically interpretable inferences.
We propose nonhomogeneous, hierarchical Bayesian Markov models and
hidden Markov models (HMMs) with random effects for AUDs treatment
trial data. Trial subjects’ drinking behavior over time is often characterized
by flat stretches of consistent alcohol consumption, interspersed with bursts
of unusual consumption. Markov models and HMMs are well-suited to model
flat stretches and bursts, enabling them to make good predictions of future
drinking behavior (compared to other models). We incorporate covariate
and treatment effects into the transition matrices of the Markov models and
HMMs, which allows a rich description of the evolution of a subject’s drink-
ing behavior over time. The inclusion of random effects into these models
allows them to account for unobserved heterogeneity on the individual level.
Furthermore, the HMM, which this paper focuses on more than the Markov
model, contains features that lend themselves to useful clinical interpreta-
tions, and provides a quantitative model of a widely used theoretical model
for relapses known among alcohol researchers as the cognitive-behavioral
model.
As an illustration, we fit these models to a large (N = 240 individuals,
T = 168 time points) data set from a clinical trial of the drug Naltrexone
that was conducted at the Center for Studies of Addictions (CSA) at the
University of Pennsylvania. We fit the models using MCMC methods, and
examine their fits with respect to various clinically important statistics using
posterior predictive checks. These statistics include such things as the time
until a subject consumes his or her first drink, the proportion of days in
which a subject drinks, and various measures of serial dependence in the
data. We also estimate the treatment effect in a novel way by estimating its
effect on transitions between latent states.
This paper builds on recent work in using HMMs for large longitudi-
nal data sets. Altman (2007) unifies previous work on HMMs for multi-
ple sequences [Humphreys (1998), Seltman (2002)] by defining a new class
of models called Mixed Hidden Markov Models (MHMMs), and describes
a number of methods for fitting these models, which can include random
effects in both the hidden and conditional components of the likelihood.
The models we fit are similar to those described in Altman (2007), but our
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data sets are substantially larger, and we choose a different method for fit-
ting the models, using a Bayesian framework outlined by Scott (2002). This
work also provides another example of using HMMs for health data, as was
done by Scott, James and Sugar (2005) in a clinical trial setting with many
fewer time points than the one examined here.
The rest of the paper is organized as follows: Section 2 introduces the
the clinical trial that generated the data to which we fit our models, and
discusses existing models and the motivation for new models. Section 3 in-
troduces the HMM and Markov model that we fit to the data. Section 4
describes the MCMC algorithm we used to fit the models and some model
selection criteria we considered when comparing the fits of each model. Sec-
tion 5 provides a basic summary of the parameter estimates of the models.
Section 6 discusses the effects of the treatment and other covariates in terms
of the transition probabilities and the stationary distribution of the HMM.
Section 7 discusses the fit of the HMM via posterior predictive checks of
some common alcohol-related statistics, and compares the fit of the HMM
to that of the Markov model in terms of the serial dependence structure
of the data. Section 8 discusses how the HMM can be used to provide a
new definition of a relapse, which is a well known problem in the alcohol
literature. Last, Section 9 provides a summary.
2. Background and data. Before introducing the models we fit, we dis-
cuss the features of the AUD treatment clinical trial from which we collected
our data, some existing models for alcohol data and the motivation for using
Markov models and HMMs.
2.1. Data description. The data set to which we fit our models is from
a clinical trial of a drug called Naltrexone conducted at the CSA at the
University of Pennsylvania. It contains daily observations from N = 240
subjects over T = 168 days (24 weeks, or about 6 months). The subjects
were volunteers who had been diagnosed with an AUD, and were there-
fore prone to greater than average alcohol consumption and more erratic
drinking behavior than individuals without an AUD diagnosis. The sub-
jects self-reported their alcohol consumption, making measurement error a
likely possibility. Immediately prior to the trial, the subjects were required
to abstain from drinking for at least three days as a detoxification measure.
Subjects recorded their daily consumption in terms of a standard scale in
alcohol studies, where “one standard drink” represents 1.5 oz. of hard liquor,
or 5 oz. of 12% alcohol/volume wine, or 12 oz. of (domestic US) beer. In
order to reduce the influence of outliers and possible measurement error, it is
common [Anton et al. (2006)] to code the number of drinks consumed as an
ordinal variable with three levels, corresponding to no drinking (0 drinks),
light drinking (1–4 drinks) and heavy drinking (four or more standard drinks
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Fig. 1. The time series plot of alcohol consumption for Subject 34. The vertical axis has
tickmarks at 1 (0 drinks), 2 (1–4 drinks) and 3 (5 or more drinks).
for women, five or more standard drinks for men). A complete description
of the trial is available in Oslin et al. (2008).
A sample series for one of the subjects is plotted in Figure 1, and the
entire collection of 240 time series are represented in Figure 2. The overall
frequencies of the dependent variable are the following: 0 drinks (Y = 1,
68%), 1–4 drinks (Y = 2, 7%), 4/5 or more drinks for women/men (Y = 3,
8%), with 17% of observations missing.
We include 4 covariates in the models we fit:
1. Treatment. Half the subjects were randomly assigned to receive the drug
Naltrexone, and the other half were assigned a placebo.
2. Sex. There were 175 men in the study, and 65 women.
3. Previous drinking behavior. Each study participant was asked to es-
timate the proportion of days prior to the study during which they
drank, and during which they drank heavily. We used these two vari-
ables, denoted D(i,drink) and D(i,heavy), to calculate the proportion of days
prior to the trial during which each subject drank moderately, denoted
D(i,moderate) =D(i,drink) −D(i,heavy), and then created a “previous drink-
ing behavior” index, Zi =D(i,moderate) + 2D(i,heavy) ∈ [0,2]. This variable
is a univariate summary of a subject’s previous drinking behavior which
is approximately unimodal.
4. Time. We measure time in days from 1,2, . . . , T = 168. Subjects did not
necessarily participate during the same stretch of actual calendar days,
so this variable is only a measure of the relative time within the clinical
trial.
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Prior to fitting the models, we scale these 4 input variables to have a mean
of zero and a standard deviation of 1/2, so that the regression coefficients
are comparable on the same scale. The ordinal drink counts and covariates
for all 240 subjects are available as supplementary material in Shirley et al.
(2009).
2.2. Existing models. Current models for alcohol data range from rela-
tively simple models that compare univariate summary statistics among dif-
ferent treatment groups to more complex failure time models, linear mixed
models and latent transition models. Wang et al. (2002) provide a good
review and a discussion of why very simple summary statistics are not ad-
equate for modeling drinking outcomes over time. Some examples of such
summary statistics are average number of drinks per day and percentage of
days abstinent. Average drinks per day, for example, might not differentiate
between one subject who drinks moderately every day of the week and an-
other subject who abstains from drinking during the week, and then binges
on the weekend. Percentage of days abstinent, on the other hand, does not
differentiate between light and heavy drinking, and does not provide infor-
mation about the pattern of abstinence across time.
Wang et al. suggest the use of multivariate failure time models for alco-
hol data. These models can be used to predict the amount of time before
Fig. 2. A representation of the observed alcohol consumption time series for all N = 240
subjects in the clinical trial. They are approximately sorted from top to bottom (within
their treatment group) in order of increasing alcohol consumption.
6 K. SHIRLEY ET AL.
the next relapse. One shortcoming of such models is that they require a
strict definition of a relapse in order to define an “event.” Although alco-
hol researchers agree on a conceptual definition of a relapse as a failure to
maintain desired behavior change, they do not agree on an operational def-
inition of relapse [Maisto et al. (2003)]. For example, do two days of heavy
drinking separated by a single day of abstinence constitute two relapses or
just one? Does one isolated day of heavy drinking constitute a relapse or
just a “lapse”? Any inference drawn from a multivariate failure time model
is conditional on the definition of a relapse. Maisto et al. (2003) show that
the choice of relapse definition makes a meaningful difference in estimates
of relapse rates and time to first relapse.
McKay et al. (2006) review GEE models for repeated measures alcohol
data. Although GEE models are useful in many ways, they are best suited
to estimate the population mean of drinking given a set of covariates, rather
than to make predictions for an individual given the individual’s covariates
and drinking history. Latent transition models, which are closely connected
to HMMs, have been proposed in the literature on addictive behavior [e.g.,
Velicer, Martin and Collins (1996)]. These models typically require a multi-
variate response vector at each time point, and are fit for data with a small
number of time points, whereas our data have a univariate response at each
time point and a long time series for each subject.
Mixed effects models are in principle well suited to making individual pre-
dictions [McKay et al. (2006)], but a rich structure for the serial correlation
must be considered to accommodate the flat stretches and bursts nature of
alcohol data, something which has not been considered thus far in the al-
cohol research literature. This paper introduces two such models—a mixed
effects HMM and a mixed effects Markov model for alcohol data.
2.3. Motivation for a Markov model or HMM. One of the important
goals of this research is to fit a model to alcohol data that can provide a rich
description of the changes in a subject’s drinking behavior through time. A
first-order Markov (chain) model is a suitable starting point in the search
for such a model. It models the observed data at a high resolution—daily
observations—as opposed to some lower-dimensional summary statistic of
the data, such as the time until the first relapse. By modeling the obser-
vations themselves, we can infer the distribution of any lower-dimensional
summary statistic we wish after fitting the model. The serial dependence
structure of a Markov model, however, is such that it may not be suitable
for data that exhibit long-term dependence.
The HMM is an attractive alternative to the first-order Markov model
because its serial dependence structure allows for longer-term dependence.
As we have stated previously, drinking behavior among individuals fol-
lowing their AUD treatment is erratic, commonly exhibiting flat stretches
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and bursts, creating long-term dependence. Longitudinal data of this form
suggest that a parameter-driven model might fit the data better than an
observation-driven model. Cox (1981) originally coined the term parameter-
driven for models in which an underlying, potentially changing “parameter
process” determines the distribution of observed outcomes through time,
such that the observed outcomes depend on each other only through the un-
derlying parameter process. Observation-driven models, on the other hand,
model observed outcomes directly as functions of previously observed out-
comes. State-space models and HMM’s (which are a subset of state-space
models) are widely used examples of parameter-driven models.
A second, very important motivation for the HMM for alcohol data is
its potential clinical interpretation: it is a quantitative model that closely
corresponds to a well-developed theoretical model of relapse known as the
cognitive-behavioral model of relapse. This theory suggests that the cause
of an alcohol relapse is two-fold: First, the subject must be in a mental
and/or physical condition that makes him or her vulnerable to engaging in
an undesired level of drinking. In other words, if the subject were given an
opportunity to drink alcohol, he or she would be unable to mount an effective
coping response, that is, a way to avoid drinking above some desired level
(usually abstinence or a moderate level of drinking). A subject’s ability to
cope can depend on time-varying cognitive factors, such as expectations of
the results of drinking, time-varying noncognitive factors, such as level of
stress, desire to drink and social support, and background variables such
as age or sex. The second condition that must be present for a relapse is
that the subject encounters a high-risk drinking situation, which is a setting
associated with prior heavy alcohol use. Common examples are a negative
mood, interpersonal problem(s) and an invitation to drink. McKay et al.
(2006) and Marlatt and Gordon (1985) contain more detailed discussions of
the traditional cognitive-behavioral model of relapse, and Witkiewitz and
Marlatt (2004) update Marlatt and Gordon (1985).
The HMM connects to the cognitive-behavioral model of relapse in the
following way: The hidden states in the HMM correspond to the vulnerability
of the subject to drinking if faced with a high risk situation, and the number
of drinks consumed on a given day is affected by the subject’s vulnerability to
drinking on the given day (the hidden state) and whether the subject faced
a high-risk drinking situation on that day. The conditional distributions of
the observations given the hidden states model the prevalence of high-risk
drinking situations for each hidden state. Interpreting the HMM this way
suggests that relapse is not necessarily an observable state—it is a hidden
state that presumably leads to heavy drinking with higher probability than
other states, but not with certainty. Via this correspondence to the cognitive-
behavioral model of relapse, the HMM has potential to make an important
contribution to the alcohol literature in its ability to provide quantitative
insight into a popular qualitative model for relapse.
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3. The models. The data we wish to model consist of categorical ob-
servations Yit ∈ (1,2, . . . ,M), for subjects i= 1, . . . ,N , and time points t=
1, . . . , ni (where ni = 168 for all subjects in our data set). We also observe the
p× 1 covariate vectors Xit = (Xit1,Xit2, . . . ,Xitp)
′ for each subject at each
time point. We consider two types of models in this paper: (1) a hidden
Markov model, and (2) a Markov model.
3.1. Hidden Markov model. The HMM we fit consists of a mixed effects
multinomial logit model for each row of the hidden state transition matrix,
and multinomial models for (1) the conditional distributions of the observa-
tions given the hidden states, hereafter called the conditional distributions of
the HMM, and (2) the initial hidden state distribution. The model includes
an unobserved, discrete hidden state, Hit ∈ (1,2, . . . , S) for each individual
i at each time point t, and we denote an HMM with S hidden states as an
HMM(S).
The hidden state transition matrix is an S×S matrix, in which each row
has probabilities that are modeled using a mixed effects multinomial logit
model:
p(H(i,t+1) = s|Hit = r,Xit,αir,βr) =
exp(αirs +X
′
itβrs)
1 +
∑S
k=2 exp(αirk +X
′
itβrk)
(1)
for r= 1, . . . , S, s= 2, . . . , S, i= 1, . . . ,N , and t= 1, . . . , T −1. For s= 1, the
numerator is set equal to 1, making the first category the baseline category.
The random intercepts are modeled using normal distributions, where αirs ∼
N(µrs, σ
2
rs), for i= 1, . . . ,N , r = 1, . . . , S, and s= 2, . . . , S.
The inclusion of S(S − 1) random intercepts for each subject means that
each subject’s transition matrix is fully flexible to reproduce every possible
set of cell frequencies for that subject. The regression effects, on the other
hand, are “fixed” effects that are constant across all subjects. They may,
however, be time-varying.
The conditional distributions of the HMM are multinomial distributions,
where
p(Yit =m|Hit = s,ps) = psm(2)
for m= 1, . . . ,M and s= 1, . . . , S, where ps = (ps1, ps2, . . . , psM) is a vector
of multinomial probabilities, for s = 1, . . . , S. Last, the initial hidden state
distribution for the HMM is a multinomial distribution with probability
vector pi = (pi1, . . . , piS). For the hidden Markov model, the collection of all
parameters is θ = (α,β,µ,σ,pi,P).
3.2. Markov model. The other model we consider is a first-order Markov
model, in which the set of probabilities in each row of the transition matrix
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is defined according to the same model described in Section 3.1, a mixed
effects multinomial logit model. The outcome for individual i at time t+1,
Y(i,t+1), depends on the previous observation for that individual, Yit, in the
following way:
p(Y(i,t+1) =m|Yit = j,Xit,αij,βj) =
exp(αijm +X
′
itβjm)
1 +
∑M
k=2 exp(αijk +X
′
itβjk)
(3)
for j = 1, . . . ,M , m= 2, . . . ,M , i= 1, . . . ,N , and t= 1, . . . , T − 1. As before,
for m= 1, the numerator equals 1. The random intercepts are given normal
distributions, where αijm ∼N(µjm, σ
2
jm), for i= 1, . . . ,N , j = 1, . . . ,M , and
m= 2, . . . ,M .
The initial values, Yi1, for i= 1, . . . ,N , are modeled as i.i.d. draws from a
multinomial distribution with probability vector pi = (pi1, . . . , piM ). For the
Markov model, the collection of all parameters is θ = (α,β,µ,σ,pi).
3.3. Missing data. Following Oslin et al. (2008)’s analysis of the trial we
are considering, we will assume that the missing data is missing at random,
that is, the missingness mechanism is independent of the missing data given
the observed data and covariates. For the HMM, we make the additional
assumption that the missingness mechanism is independent of the hidden
states given the observed data and covariates, in order to do inference on
the hidden states as well as the model parameters [Gelman et al. (2004),
Chapter 21]. A sensitivity analysis for this assumption is a valuable topic for
future research, but outside the scope of this paper. There is a considerable
literature on missing data in longitudinal addiction studies, including Albert
(2000, 2002) and Longford et al. (2000), which might guide one’s choices
regarding the design of a sensitivity analysis.
3.4. Discussion of models. The first-order Markov model is nested within
an HMM withM or more hidden states. Also, an HMM with S hidden states
is nested within an HMM with more than S hidden states. An HMM is a
mixture model, whose mixing distribution is a first-order Markov chain.
It has been applied to problems in numerous fields [for lists of examples,
see MacDonald and Zucchini (1997), Scott (2002) or Cappe, Moulines and
Ryden (2005)], but not previously to alcohol consumption time series data.
4. Model fits and comparison.
4.1. Model fits. We fit the HMM(3) and the Markov model using
Metropolis-within-Gibbs MCMC algorithms whose details are described in
the Appendix. We ran three chains for each model and discarded the first
10,000 iterations of each chain as burn-in. We used the next 10,000 itera-
tions as our posterior sample and assessed convergence using the potential
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scale reduction factor [Gelman et al. (2004)], and found that Rˆ < 1.02 for all
parameters in the models. Visual inspection of trace plots provide further
evidence that the posterior samples converged to their stationary distribu-
tions. The autocorrelation of the posterior samples of β were the highest of
all the parameters, such that total effective sample size from three chains
of 10,000 iterations each was between 200 and 300. The transition proba-
bilities for each subject and time point, on the other hand, had much lower
autocorrelations, such that for a given transition probability, three chains
of 10,000 iterations each yielded a total effective sample size of about 5000
approximately independent posterior samples. Since transition probabilities
are the most important quantity of interest in our analysis, the Monte Carlo
error associated with our estimated treatment effects is small.
All the parameters were given noninformative or weakly informative pri-
ors, which are described in the Appendix. The algorithm for both mod-
els consisted of sampling some of the parameters using univariate random-
walk Metropolis steps, and others from their full conditional distributions.
When fitting the Markov model, if a subject’s data were missing for tmis
steps, we computed the (tmis + 1)-step transition probability to calculate
the likelihood of the current parameters given the data, and alternated
between sampling Ymis ∼ p(Ymis|Yobs,X,θ) and θ ∼ p(θ|Yobs,Ymis,X).
Likewise for the HMM, we alternated sampling H ∼ p(H|Yobs,X,θ) and
θ ∼ p(θ|Yobs,H,X). We sampled H using a forward-backward recursion as
described in Scott (2002), substituting (tmis+1)-step transition probabilities
between hidden states when there was a string of tmis missing observations
for a given subject.
The hidden states of an HMM have no a priori ordering or interpreta-
tion, and as a result, their labels can “switch” during the process of fitting
the model from one iteration of the MCMC algorithm to the next, with-
out affecting the likelihood [Scott (2002)]. We experienced label switching
when the starting points for the MCMC algorithm were extremely widely
dispersed, but when we used more narrowly dispersed starting points, each
chain converged to the same mode of the S! symmetric modes of the poste-
rior distribution. We discuss our procedure for selecting starting points for
the parameters in the MCMC algorithms in the Appendix.
4.2. Model comparison. We present the DIC of the two models in this
section, but we ultimately don’t rely on it as a formal model selection crite-
rion. Instead we use posterior predictive checks to compare the two models,
and combine this analysis with existing scientific background knowledge to
motivate our model choice, which suggests that the HMM(3) is more promis-
ing.
The Markov model converged to a slightly lower mean deviance than the
HMM(3), where the deviance is defined as D(Y,θ) =−2 log p(Y|θ). Table 1
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contains a summary of the deviance for both models, where D¯(Y,θ) is the
mean deviance across posterior samples of θ, and D(Y, θ¯) is the deviance
evaluated at the posterior mean, θ¯. For the Markov model, deviance calcu-
lations were done using the parameter vector θ = (α,β,pi), whereas for the
HMM(3), the parameter vector θ = (α,β,pi,P). That is, for both models,
we compute the probability of the data given the parameters in the like-
lihood equation, and don’t factor in the prior probabilities of the random
effects, p(α|µ,σ). The Markov model has a higher estimated effective num-
ber of parameters, pD, and also has a higher DIC, which is an estimate of a
model’s out of sample prediction error [Spiegelhalter et al. (2002)]. The esti-
mates of pD and DIC had low Monte Carlo estimation error (approximately
±5), as estimated by recomputing them every 1000 iterations after burn-in.
Model selection criteria such as BIC and DIC, however, are well known
to be problematic for complicated hierarchical models, mixture models such
as an HMM and models with parameters that have non-normal posterior
distributions [Spiegelhalter et al. (2002), Scott (2002)]. For this reason, we
choose not to select a model [between the Markov model and the HMM(3)]
based on formal criteria such as these. Instead, we examine the fit of each
model using posterior predictive checks and highlight each of their advan-
tages and disadvantages. We ultimately focus most of our attention on the
HMM(3) because of its potential for clinical interpretability in terms of the
cognitive behavioral model of relapse (Section 2.3), which suggests that a
relapse is not equivalent to a heavy drinking episode, but rather, it may be
better modeled as an unobserved state of health.
5. Interpreting the model fits. We begin by looking at the parameter
estimates of the Markov model and HMM(3).
5.1. Conditional distributions of the HMM. The hidden states of the
HMM(3) can be characterized by their conditional distributions, which are
multinomial distributions with three cell probabilities, psm = p(Yit =m|Hit =
s) for outcomes m= 1,2,3 and hidden states s= 1,2,3. The posterior dis-
tributions of psm are summarized in Table 2. Each conditional distribution
puts most of its mass on a single outcome, and we therefore label the hid-
den states according to which outcome has the largest probability under
Table 1
Summary of the DIC of the models
Model D¯(Y, θ) D(Y, θ¯) pD DIC
Markov 19,871 19,183 688 20,560
HMM(3) 19,902 19,303 599 20,500
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their associated conditional distributions: The first hidden state is labeled
“Abstinence” (“A”), the second hidden state is labeled “Moderate Drink-
ing” (“M”), and the third hidden state is labeled “Heavy Drinking” (“H”).
The Moderate and Heavy Drinking states each leave a small, but significant
(as indicated by their 95% posterior intervals excluding zero) probability
of a different outcome from moderate (Y = 2) and heavy (Y = 3) drinking,
respectively.
5.2. Transition probabilities. The posterior distributions of the parame-
ters associated with the transition matrices for the Markov model and the
HMM(3) are similar. This is not surprising, considering that if p11 = p22 =
p33 = 1, then the HMM(3) is equivalent to the Markov model, and from Ta-
ble 2 we see that the estimates of p11, p22 and p33 are almost equal to 1. We
will not discuss the posterior distributions of these parameter estimates here,
though, because the form of the multinomial logit model for each row of the
transition matrices makes them somewhat difficult to interpret. Instead, we
present the estimated mean transition matrices for both models:
QˆMarkov =

0.97 0.02 0.010.75 0.21 0.04
0.45 0.03 0.52

 , QˆHMM(3) =

0.98 0.01 0.010.72 0.26 0.02
0.41 0.02 0.57

 .(4)
These are the posterior mean transition matrices for the Markov model and
HMM(3) for a subject with average random intercepts, and the average value
for each covariate: Xi = (0,0,0,0)
′. Formally,
QˆModel(j,m) =
1
G
G∑
g=1
(
exp (µ
(g)
jm)
1 + exp (µ
(g)
j2 ) + exp (µ
(g)
j3 )
)
for j = 1, . . . ,3, m = 2,3, and posterior samples g = 1, . . . ,G, where for
m = 1, the numerator is replaced by the value 1. Setting the time vari-
able equal to zero corresponds to calculating the mean transition matrix on
day 84 of the 168-day clinical trial. Note that Sex and Treatment are bi-
nary variables, which means that no individual subject has the exact design
matrix used to calculate the transition probabilities in Equation (4). Later
Table 2
Conditional Distributions of the HMM(3)
Posterior mean Posterior stand. errors State label
pˆ1 (0.997, 0.003, 0.000) (0.001, 0.001, 0.000) “Abstinence”
pˆ2 (0.026, 0.956, 0.018) (0.012, 0.012, 0.005) “Moderate Drinking”
pˆ3 (0.031, 0.004, 0.966) (0.006, 0.002, 0.007) “Heavy Drinking”
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in Section 6 we will more carefully analyze the transition matrices bearing
this in mind, but for now we are only interested in rough estimates of the
transition probabilities.
The estimates of the mean transition probabilities are very similar be-
tween the two models. One interesting feature is that, on average, for both
models, the most persistent state is Abstinence, the second most persistent
state is Heavy Drinking, and the least persistent state is Moderate Drink-
ing. The Moderate Drinking and Heavy Drinking states don’t communicate
with each other with high probability under either model (for a person with
average covariates). We fully analyze the covariate effects on the transition
matrix in Section 6.
5.3. Initial state probabilities. The posterior distributions of the initial
state probability vectors for the two models were nearly identical, where
their posterior means were pˆi = (93.6%,3.4%,3.0%) for both models, and
the posterior standard deviation was about 1.5% for all three elements of pi
(for both models).
6. The treatment effect. To estimate the effects of covariates, including
the treatment variable, on the transition probabilities of the hidden state
transition matrix for the HMM(3) (where a similar analysis could be done
for the Markov model if desired), we perform average predictive compar-
isons as described in Gelman and Hill (2007), pages 466–473. The goal is to
compare the value of some quantity of interest, such as a transition proba-
bility, calculated at two different values of an input variable of interest, such
as Treatment, while controlling for the effects of the other input variables.
Simply setting the values of the other inputs to their averages is one way to
control for their effects, but doing so can be problematic when the averages
of the other inputs are not representative of their distributions, as is the case
for binary inputs, for example. An average predictive comparison avoids this
problem by calculating the quantity of interest at two different values of the
input of interest while holding the other inputs at their observed values, and
averaging the difference of the two quantities across all the observations.
In the context of the HMM(3), if we denote the input variable of interest
by U , and consider high and low values of this variable, u(hi) and u(lo), and
denote the other input variables for individual i at time t by Vit, then we
can compute the average difference in transition probabilities calculated at
the two values of U as follows:
Bjm(U) =
1
N(T − 1)
×
N∑
i=1
T−1∑
t=1
[P(H(i,t+1) =m|Hit = j,θ, uit = u
(hi),vit)(5)
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−P(H(i,t+1) =m|Hit = j,θ, uit = u
(lo),vit)]
for j,m= 1, . . . ,3. We call Bjm(U) the average transition probability differ-
ence for input variable U for transitions from hidden state j to hidden state
m.
Figure 3 displays 95% posterior intervals for the average transition prob-
ability differences for all four covariates that are incorporated into the tran-
sition matrix of the HMM(3), for all 32 = 9 possible transitions. The treat-
ment, Naltrexone, appears to have a moderate negative effect on the prob-
abilities of a transition from Heavy-to-Heavy and Abstinent-to-Heavy, as
is evidenced by the fact that the 95% posterior intervals for these aver-
age transition probability differences lie mostly below zero [the intervals
are (−19.9%,2.5%) and (−4.1%,1.1%), respectively]. Heavy-to-Heavy tran-
sitions occur, on average, about 9% less often for those using Naltrexone, and
Abstinent-to-Heavy transitions occur, on average, about 1.5% less often for
those using Naltrexone. This is a desired outcome: These intervals indicate
that Naltrexone may be effective in improving certain aspects of drinking
behavior, because a reduction in these transition probabilities would most
likely result in a decrease in heavy drinking, according to the estimated
conditional distributions associated with these hidden states. Conversely,
Naltrexone appears to have a significant positive effect on the probability
of a transition from Moderate-to-Heavy, occurring about 3.5% more often
on average for Naltrexone-takers, which, on average,would lead to increased
heavy drinking.
Other covariate effects visible in Figure 3 include the following:
• All else being equal, women are more likely than men to make transitions
into the Moderate and Heavy states.
• Drinking heavily in the past is associated with higher transition probabil-
ities into the Moderate and Heavy states.
• Transitions into the Moderate and Heavy states are more likely to occur
later in the clinical trial than earlier in the clinical trial.
• The 95% intervals for the average transition probability differences are
noticeably shorter for transitions out of the Abstinence state, because
that is where subjects are estimated to spend the most time, and with
more data comes more precise estimates.
6.1. Covariate effects on the stationary distribution. To further sum-
marize the effects of the covariates on drinking behavior, we can compute
average stationary probability differences instead of average transition prob-
ability differences. This provides a slightly more interpretable assessment of
the treatment effect on drinking behavior because the stationary distribution
contains a clinically important summary statistic: the expected percentages
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Fig. 3. 95% posterior intervals of the average transition probability differences for each of
the four input variables and for each of the nine transition probabilities in the HMM(3). For
the binary input variables Treatment and Sex, we set the high values, u(hi), as Naltrexone
and Female, and the low values, u(lo), as Control and Male, respectively, and for the
continuous input variables, Past Drinking and Time, we set the high and low values to the
mean ± 1 sd of their respective distributions.
of time a subject will spend in each hidden state, given that the HMM is sta-
tionary. An effective treatment would reduce the expected amount of time
spent in the Heavy Drinking state.
The model we fit is a nonhomogenous (i.e., nonstationary) HMM, so, by
definition, it does not have a stationary distribution. We would still, however,
like to make inferences about a subject’s long-term behavior conditional on
whether or not he or she took Naltrexone. One strategy for estimating how
much time will be spent in each state is through posterior predictive simu-
lations of the hidden states themselves. Another strategy, which we discuss
here, is to compute the stationary distribution of the hidden state transition
matrix on the last day of the trial for all subjects. This can be interpreted
as a way of projecting drinking behavior into the long-term future without
extrapolating the effect of time beyond the clinical trial, by assuming that
16 K. SHIRLEY ET AL.
Fig. 4. 95% posterior intervals of average stationary probability differences for the three
covariates (other than time) incorporated into the HMM(3) transition matrix.
each subject has reached a stationary pattern of behavior at the end of the
trial. Figure 4 contains 95% posterior intervals of the average stationary
probability differences for the covariates Treatment, Sex and Past Drinking,
where the HMM(3) is assumed to be stationary beginning on the last day
of the trial.
On average, the use of Naltrexone appears to decrease the amount of time
spent in the Heavy drinking state by about 5%, and increase the amount
of time spent in the Moderate drinking state by the same amount. Women
and subjects who drank heavily prior to the trial also are predicted to spend
more time in the Heavy drinking state in the long run. These estimates
are consistent with the average transition probability differences displayed
in Figure 3, and provide a slightly more concise summary of the covariate
effects.
6.2. Heterogeneity among individuals. Another important aspect of the
model fit is the degree of heterogeneity that is present among individuals,
which is modeled by the random intercepts as well as the covariate effects
embedded in the HMM(3) hidden state transition matrix. To explore this,
we calculate the posterior mean of each of the 32 = 9 transition probabilities
for each subject i at a given time point t,
Qˆit(r, s) =
1
G
G∑
g=1
P(H(i,t+1) = s|Hit = r,Xit,α
(g),β(g),pi(g))(6)
for i= 1, . . . ,N , t= 84 (the midpoint of the trial), r, s= 1,2,3, and posterior
samples g = 1, . . . ,G. In Figure 5 we plot density estimates of each of the
32 = 9 sets of N transition probability posterior means (measured at time
t= 84).
The density estimates of these posterior mean transition probabilities rep-
resent heterogeneity among individuals from two sources: the random inter-
cepts and the covariate effects. By comparing Figure 3 to Figure 5, it is clear
that the differences in mean transition probabilities among individuals are
larger than the differences implied by covariate effects alone. The largest av-
erage transition probability differences, illustrated in Figure 3, were approx-
imately ±0.2, and were due to differences in the subjects’ previous drinking
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Fig. 5. Density estimates of the 32 = 9 sets of posterior mean transition probabilities in
the HMM(3), where the posterior means are calculated for each individual at the midpoint
of the trial (t = 84), and each of the 9 the transition probability densities are therefore
estimated using N = 240 data points.
behavior. We see from Figure 5, however, that the differences between tran-
sition probabilities across individuals is often greater than 0.5, and can be
as large as 1, such that a particular transition is certain for one individual,
and has zero probability for another individual. Specifically, transition prob-
abilities are relatively similar across subjects when the subjects are in the
Abstinent state, but are highly variable across subjects when the subjects
are in the Moderate and Heavy states. If a subject is in the Abstinent state,
their probability of remaining in the Abstinent state for an additional day is
above 80% for most subjects, regardless of the values of his or her observed
covariates and random intercepts (which represent the effects of unobserved
covariates). On the other hand, if a subject is in the Moderate or Heavy
state, his or her next transition is highly uncertain: depending on the indi-
vidual, he or she may have a very high or a very low probability of remaining
in the same state for another day. The fact that the random intercepts are
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explaining more variation in the estimated transition probabilities than any
individual covariate suggests that it might be useful for future studies to
record as many additional covariates as possible. Such a design might re-
duce the amount of unexplained heterogeneity across individuals that must
be accounted for by the random intercepts. This result also highlights the
need for random effects in this particular model, as well as the need for
studying the inclusion of random effects into HMMs in general, as they can
have a profound effect on the fit of the model.
7. Goodness of fit of the models. In this section we use posterior pre-
dictive checks to examine the fit of the HMM(3) and the difference between
the HMM(3) and the Markov model.
7.1. Mean and variance of drinking days across subjects. As a first check
of the goodness of fit of our model, we performed posterior predictive checks
[Gelman et al. (2004)] of the mean and variance of the number of moderate
and heavy drinking days across all subjects (a total of four statistics of
interest). The specific steps we took are as follows: For each of these four
statistics, we computed its observed value from the data, and denoted this
t(Yobs). Then, for posterior samples g = 1, . . . ,G, we
1. simulated αrep|µ(g),σ(g), where αrep is a set of random effects to repre-
sent a new set of subjects from the population,
2. simulated Hrep|αrep,β(g),pi(g),X,
3. simulated Yrep|Hrep,P(g), and
4. computed t(Yrep),
where the parameters superscripted by (g) are taken from the posterior sam-
ples obtained from the MCMC algorithm. By simulating new random effects,
αrep, we are checking to see that the model adequately captures heterogene-
ity across subjects. We compared the values of t(Yobs) to the distributions
of t(Yrep) for the four statistics of interest, and found no evidence of a lack
of fit; that is, the observed values of t(Yobs) were not located in the extreme
tails of the distributions of t(Yrep). Table 3 contains summaries of these
posterior predictive checks.
7.2. First drinking day. Another common quantity of interest in alcohol
research is the time until a subject’s first drink, also known as the first
drinking day, or FDD. This variable is often treated as the primary outcome
in clinical trials for AUD treatments. We performed a posterior predictive
check of the mean and variance of this statistic across subjects using the
same steps as are outlined in Section 7.1. This check relates not only to
the heterogeneity of behavior across subjects, but also to the patterns of
drinking behavior across time.
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Table 3
Summaries of the posterior predictive checks of the mean and variance of moderate and
heavy drinking days. s2mod and s
2
heavy are the variances of the number of moderate and
heavy drinking days across subjects, respectively, and x¯mod and x¯heavy are the means of
the number of moderate and heavy drinking days across subjects, respectively. The middle
5 columns contain the 2.5th, 25th, 50th, 75th and 97.5th quantiles of the distributions of
t(Yrep), and the rightmost column contains the observed values t(Yobs), and the
proportion of the simulated statistics that were less than these values
Statistic 2.5% 25% 50% 75% 97.5% Observed (quantile)
s
2
mod 335.9 393.5 430.6 477.6 554.6 524.8 (0.92)
s
2
heavy 400.6 502.9 558.4 608.4 722.7 618.5 (0.78)
x¯mod 9.8 10.5 10.9 11.3 12.1 11.3 (0.73)
x¯heavy 11.6 12.7 13.4 13.9 15.1 13.7 (0.65)
Fig. 6. (a) The histogram of observed FDD; (b) the histogram of simulated values of the
mean FDD across subjects; (c) the histogram of simulated values of the standard deviation
of FDD across subjects; (d) the histogram of the simulated distribution of Never-Drinkers.
In each case, the values calculated from the simulated distributions were computed by ig-
noring the days that were missing for each subject, so that the simulated values are directly
comparable to the observed values, denoted by the vertical dotted lines in each figure.
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Figure 6 contains plots summarizing the posterior predictive checks of
FDD. Figure 6(a) contains a histogram of the observed values of FDD for
all subjects; the empirical distribution is skewed to the right, and contains
only 184 points, because 56 subjects exhibit a combination of missing data
or abstinence throughout the whole trial. Figures 6(b) and 6(c) contain his-
tograms of the simulated distributions of the mean and standard deviation
of FDD across subjects, for the subset of subjects who drank at least once,
with dotted lines representing the observed values. The observed values lie
within the center parts of their simulated distributions, indicating an ade-
quate fit. Last, Figure 6(d) contains a histogram of the simulated values of
the number of “Never-Drinkers” among the 240 subjects, that is, those who
never drink throughout the course of the clinical trial, via a combination of
abstinence and missing data. The observed number of Never-Drinkers is 56
(out of 240), but in general, the model reproduces data sets in which there
are about 20–50 Never-Drinkers. This indicates a slight lack of fit—there
appears to be a set of individuals among the subjects (who never drink)
whose behavior is not well captured by the model. A similar lack of fit in
other settings has been remedied by the use of a mover-stayer model [Albert
(1999), Cook, Kalbfleisch and Yi (2002)], in which a latent class of subjects
is constrained to exhibit constant behavior over the whole time series, and
membership in this class is estimated from the data. On the other hand, it
may be clinically justifiable to suggest that a subject always has a nonzero
probability of drinking, even if in a given sample of days he or she never
drinks. In the fit of the HMM(3), the prior distributions on the random
effects means (µ) virtually prevent any subject from having a transition
probability of zero by design. Transition probabilities can be very small, but
never zero.
7.3. Patterns across time. Further posterior predictive checks demon-
strate that the HMM(3) is able to model nonlinear, nonstationary and het-
eroscedastic drinking behavior. To see this, we divided the trial period of
24 weeks into 6 blocks of 4-week time periods, and performed posterior pre-
dictive checks on the mean and variance of abstinent, moderate and heavy
drinking days within each time period. In other words, we recreated the
four posterior predictive checks illustrated in Table 3 for data in each of six
time periods, and extended the analysis to include the mean and standard
deviation of abstinent days across subjects for each time period.
Figure 7 contains a visual summary of all 36 of these posterior predic-
tive checks, where the x-axis in each of the six plots is time. The boxplots
in each of the six plots display the distributions of the simulated values of
the given statistics during each time period, and the black lines display the
observed values of these statistics. The plot in the upper left corner, for
example, shows that the observed mean of abstinent days (across subjects)
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decreased over the course of the clinical trial, from about 23 days out of a
possible 28 days in the first 4-week time period to about 18 out of 28 days
in the last 4-week time period, and that this decreasing trend is nonlinear.
The HMM(3) captures this nonlinear trend, with a slight underestimate of
the mean number of abstinent days toward the end of the trial (in the last
4–8 weeks). Furthermore, the lower left-hand plot shows that the standard
deviation of the number of days of abstinence (across subjects) increases as
the trial progresses, also in a nonlinear way. The HMM(3) adequately mod-
els this heteroscedasticity, with only a slight underestimate of the standard
deviation of abstinent days in the last 8–12 weeks. Regarding moderate and
heavy drinking, the model appears to adequately describe both the mean
and standard deviation of moderate drinking days for each time period, but
fails to fully capture the apparent quadratic trend in the mean and standard
deviation of heavy drinking through time (both of these quantities appear
to increase from the beginning of the trial until the middle of the trial, and
then decrease until the end of the trial). The observed values of these statis-
tics, though, never fall outside of the tails of the simulated distributions,
indicating no major lack of fit. These posterior predictive checks illustrate
the flexibility of the HMM as it is formulated in Section 3.1. Note that for
categorical outcomes, the mean and sd are determined by the same sets of
parameters, and that the observed percentages of each categorical outcome
are negatively correlated by definition (because more realizations of one out-
come results in fewer realizations of each of the other outcomes), so that the
posterior predictive checks in Figure 7 are not independent.
7.4. Serial dependence comparison. To analyze the difference between
the Markov model and the HMM(3), we look for patterns among the data
in which one model fits better than the other. One striking such pattern
is related to the way that the two models handle the serial dependence
in the data. Their difference is apparent in the posterior distributions of
the estimated probabilities (or, equivalently, the deviances) of certain data
points. The HMM(3) fits better than the Markov model to the third data
point in sequences of the form (3,1,3), (1,2,1), (2,3,2), etc., where two days
of equal consumption are interrupted by a single day of a different level of
consumption. The Markov model, on the other hand, fits better than the
HMM(3) to the third data point in sequences of the form (3,1,1), (1,2,2)
and (2,3,3), etc., where the second and third day’s consumption levels are
equal to each other and different from the first day’s consumption.
Consider Figure 8, in which 95% intervals and point estimates of the
posterior probabilities of a sequence of outcomes for Subject 186 are plotted
for both the HMM(3) and the Markov model. On day 90, the third day of
a (3,1,3) sequence, the HMM(3) fits the data better, because the subject’s
reported abstinence on day 89 did not necessarily represent a change in
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Fig. 7. Posterior predictive checks of the mean and standard deviation of all three drink-
ing outcomes in each of the six 4-week time periods during the trial. The gray shaded
boxplots display the distributions of simulated values of each statistic, and the black lines
display the observed values of these statistics. For example, for the first four weeks of the
trial, the mean number of abstinent days across subjects was about 23 days, and in 1000
post-burn-in simulations, the value of this statistic ranged from approximately 21–24 days,
indicating no major lack of fit with respect to this statistic.
the hidden state during this sequence. On day 95, on the other hand, the
Markov model fits the data better, because the reported abstinence that day
was the first of many days in a prolonged sequence of abstinent behavior.
In this case both models fit poorly to the unexpected day of abstinence on
day 94, but the Markov model predicts the following day of abstinence with
high probability, whereas the HMM(3) does more smoothing across time,
and is therefore “slower” to predict the second abstinent day (on day 95).
This pattern is generally true for all triplets of the form (i, j, i) and (i, j, j),
where i and j represent observed consumption levels.
In the presence of measurement error—which is plausible given that the
subjects self-report their alcohol consumption—and in light of the cognitive
behavioral model of relapse, which suggests that a change in one’s alcohol
consumption is not necessarily equivalent to a change in one’s underlying
health state, the “smoother” fit of the HMM(3) is an advantage over the
Markov model. The notion that the underlying behavior of individuals with
an AUD is relatively steady, and that the observations are somewhat noisy,
is consistent with the cognitive behavioral model of relapse.
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7.5. Differences across subjects. To see the different drinking behaviors
across subjects, we simulated sample paths from the fitted model for each
subject using a procedure similar to the 4-step procedure outlined in Sec-
tion 7.1. This time, however, instead of simulating new random effects, αrep,
from the posterior distributions of µ and σ to represent a new sample of
subjects from the population, we simply used the posterior samples of α
directly to simulate new hidden states, Hrep, and observations, Yrep (steps
2 and 3 of the procedure). This way each set of simulated time series repre-
sents a new set of realizations for the exact same set of subjects whose data
were observed, and we can make direct comparisons between the observed
data and the simulations for each individual.
Figure 9 displays the observed drinking time series and one randomly
drawn simulated time series for four subjects whose behaviors varied widely
from each other. From the figure it is clear that the random effects in the
HMM(3) allow it to capture a wide variety of drinking behaviors. Here is a
summary of these four drinking behaviors:
1. Subject 89 is almost always abstinent, with occasional days of heavy
drinking,
2. Subject 59 drinks heavily in very frequent short bursts (typically for just
1–2 days in a row),
3. Subject 79 drinks heavily on occasion for longer periods of time (10 days
in a row appears typical),
4. Subject 5 drinks moderately for prolonged periods of time.
Fig. 8. Point estimates and vertical 95% posterior intervals for the estimated probabil-
ities of a sequence of data points for Subject 186 under both models, where the Markov
model point estimates and intervals are drawn with dashed lines. Both models essentially
fit equally well to the data in this sequence except for two points: the HMM(3) fits better
to the heavy consumption on day 90, and the Markov model fits better to the abstinence
on day 95.
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Fig. 9. A visual comparison of observed (left column) and simulated (right column) time
series for four subjects whose behavior varied widely. The HMM(3) is able to reproduce a
wide variety of behaviors via its random effects in the hidden state transition matrix.
Each of these four unique drinking behaviors is captured by the HMM(3)
through the random effects in the hidden state transition matrix.
8. A new definition of relapse. The HMM offers a new definition of a
relapse: any time point at which the probability is high that a subject is
in hidden state 3, the Heavy Drinking state. There are a variety of ways to
estimate the hidden states in an HMM, many of which are discussed in Scott
(2002). Most methods can be categorized in one of two ways: They either
maximize the marginal probability of each Hit separately, or they attempt
to find the set of sequences of hidden states H (which we think of as an
N × T array, consisting of a set of N sequences, each of length T ) that is
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collectively the most likely (i.e., the mode of the joint posterior distribution
of H). The first method requires the calculation of the marginal probabilities
of each hidden state at each time point, and then estimates the hidden state
for each subject and time point as maxs{P(Hit = s|Y,θ)}. When the hidden
state transition matrix contains zeroes, though, or has high probabilities on
the diagonal (as it does in our case for many individuals), then using the
marginal probabilities to estimate hidden states can result in a sequence
that is very unlikely, or even impossible, because maximizing the marginal
probabilities does not fully account for the dependence between consecutive
hidden states [Rabiner and Juang (1986)]. Such a sequence is not appealing
for characterizing relapse periods because our goal is to segment a subject’s
drinking time series into plausible periods of in-control drinking behavior as
opposed to out-of-control (relapse) drinking behavior.
We attempt the second type of hidden state estimation, in which we seek
to find the set of sequences H that is the most likely, given the observed
data. In the Bayesian framework, one way to do this would be to select the
sequence H(g) that occurs most often in our post-burn-in posterior samples
g = 1, . . . ,G. With such a large data set, though, it would require a huge
number of MCMC iterations to ensure that a single realization of H was
sampled twice or more. In our posterior sample, for example, the largest
amount of overlap between any two samples of H was about 93% [that is,
the pair of sets (H(i),H(j)) for i, j ∈ (1, . . . ,G) that had the most elements
in common shared about 93% of their elements]. Thus, to estimate H, we
used a different method: we computed the most likely set of sequences given
the observed data and the posterior mean, θ¯, using the Viterbi algorithm
[Rabiner and Juang (1986)]. This is similar to what is done is most frequen-
tist analyses of HMMs, in which the Viterbi algorithm is run conditional on
the MLEs of the model parameters to compute the most likely sequence(s)
of hidden states.
Figure 10 shows the observed data and the most likely hidden states
for two subjects. Subject 150 is estimated to be in the Heavy Drinking
state from about Day 10 to about Day 140, despite not drinking on a
number of days during that span. Likewise, Subject 186 is estimated to
be in the Heavy Drinking state for a prolonged period of time despite
a few days of abstinence during that time span. According to the defi-
nition of relapse that says any day spent in the Heavy Drinking hidden
state is a relapse, these subjects were both in a state of relapse for a
long, continuous period of time. This relapse definition is robust to out-
liers and measurement errors in the sense that a single day, or a brief
“burst,” among the observations does not necessarily imply a transition
in the most likely hidden state sequence. On many days, these two sub-
jects reported a single day of abstinence, preceded and followed by many
consecutive days of heavy drinking. Some definitions of relapse would be
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Fig. 10. The most likely sequence of hidden states for Subjects 150 and 186. The dark
lines represent the observed daily drink counts, and the shaded regions represent the esti-
mated hidden state at each time point, where the hidden states are numbered 1 through 3
as they are in Table 2.
sensitive to these abstinence observations, and would suggest that the sub-
ject was no longer in a state of relapse, whereas the HMM-based defini-
tion of relapse includes these days as well, because the most likely hidden
state sequence remains the same whether those observations were a 1, 2
or 3, because of the dependence structure across time that the HMM im-
poses.
Using this definition of relapse, a relapse depends on one’s unobservable
physical and mental state of health, rather than directly on one’s drink-
ing behavior. Choosing which relapse definition is best for a given purpose
requires clinical insight. Currently used definitions of relapse define what
patterns of drinking constitute a relapse a priori before looking at the data.
There is no consensus on what patterns constitute a relapse [Maisto et al.
(2003)]. An advantage of the HMM approach is that it starts with a model
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of drinking behavior and a qualitative definition of relapse (e.g., a state in
which a subject has a substantial probability of drinking heavily) and then
lets the data decide what patterns of drinking constitute a relapse. This
being said, we found evidence from earlier fits of HMMs to this data that
the HMM-based definitions of relapse are sensitive to the number of hidden
states in the model and the choice of which hidden states are categorized as
relapse states. This choice becomes harder as the number of hidden states
grows, because with more hidden states, the conditional distributions tend
to correspond less clearly to easily identifiable drinking behaviors. Thus,
using the HMM definition of relapse suggested in this section still requires
careful thought on the part of the investigator with respect to (1), the choice
of the number of hidden states, and, once that choice is made, to (2), the
choice of which hidden states will be designated as relapse states.
9. Discussion and extensions. In this paper we develop a nonhomoge-
nous, hierarchical Bayes HMM with random effects for data from a clinical
trial of an alcoholism treatment. The model is motivated by data which ex-
hibits flat stretches and bursts, as well as by the cognitive-behavioral model
for relapse that coincides with the structure of the HMM, in which subjects
make transitions through unobservable mental/physical states over time,
and their daily alcohol consumption, which is observed, depends on their un-
derlying state. A major strength of the HMM (and also of the Markov model
we propose) is that it models the daily alcohol consumption of subjects. Such
a model provides a rich description of subjects’ alcohol consumption behav-
ior over time, as opposed to some lower-dimensional random variable such
as the time until a subject’s first relapse, which provides a narrower view of
a subject’s alcohol consumption.
The fit of the model to the data reveals a number of interesting things.
The HMM with three hidden states fits well, and the hidden state tran-
sition matrix reveals that the most persistent state is abstinence, followed
by heavy drinking, followed by moderate drinking. The transition matrices,
however, vary widely among subjects, and the models, in general, are able
to reproduce a wide variety of drinking behaviors (see Figure 9). The treat-
ment in the clinical trial we analyzed, Naltrexone, appears to have a small,
beneficial effect on certain transition probabilities, as well as on the overall
percentage of time one would expect to spend in the heavy drinking state.
Posterior predictive checks reveal that the heterogeneity among individuals
is captured by the random effects in the hidden state transition matrices.
Furthermore, the HMM(3) adequately models nonstationary, nonlinear and
heteroscedastic drinking patterns across time.
Also, the HMM suggests a new definition of relapse, based on hidden
states, which is conceptually supported by the cognitive-behavioral model
of relapse, and can be compared to existing definitions of relapse to offer
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new insights into which patterns of drinking behavior are indicative of out-
of-control behavior (i.e., a substantial probability of heavy drinking).
APPENDIX: MCMC ALGORITHMS TO FIT THE MODELS
Here we present some details of the MCMC algorithms used to fit the
models.
A.1. Fitting the Markov model. The Markov model, as was described in
Section 3.2, is essentially composed ofM separate multinomial logit models,
one for each row of the transition matrix. The Markov model, however, is
substantially more difficult to fit, because the observations given the model
parameters are not i.i.d.; each observation depends on the previous one.
We incorporate a data augmentation step into the Metropolis-within-Gibbs
algorithm to fit the Markov model. First, the priors:
βmjk ∼N(0,10
2) for m= 1, . . . ,M, j = 2, . . . ,M,k = 1, . . . , p,(7)
µmj ∼N(0,10
2) for m= 1, . . . ,M, j = 2, . . . ,M,(8)
p(σmj)∼ 1 for m= 1, . . . ,M, j = 2, . . . ,M,(9)
pi ∼Dirichlet(1).(10)
We fit the Markov model with the following steps:
1. Initialize the parameters, α
(0)
ijm,β
(0)
jm, for i = 1, . . . ,N , j = 1, . . . ,M , and
m= 2, . . . ,M , using overdispersed starting values, and initialize µ
(0)
jm = 0
and σ
(0)
jm = 1 for j = 1, . . . ,M , and m= 2, . . . ,M .
2. For g = 1, . . . ,G,
(a) Sample Y
mis,(g)
i |Y
obs
i ,α
(g−1)
i ,β
(g−1) from its full conditional distri-
bution for i= 1, . . . ,N .
(b) Sample α
(g)
ijm|Y
obs
i ,Y
mis,(g)
i ,β
(g−1)
j , µjm, σjm using a univariate ran-
dom walk Metropolis sampler for i = 1, . . . ,N , j = 1, . . . ,M , and
m= 2, . . . ,M .
(c) Sample β
(g)
jmk|Y
obs,Ymis,(g),α
(g)
j using a univariate random-walk
Metropolis sampler, for j = 1, . . . ,M , m= 2, . . . ,M , and k = 1, . . . , p,
where α
(g)
j denotes the N × (M − 1) matrix of random intercepts
sampled during iteration g.
(d) Sample µ
(g)
jm|α
(g)
jm, σ
(g−1)
jm from its full conditional normal distribution
for j = 1, . . . ,M and m= 2, . . . ,M , where α
(g)
jm is the length-N vector
of random intercepts sampled during iteration g.
(e) Sample σ
(g)
jm|α
(g)
jm, µ
(g)
jm from its full conditional inverse chi-squared dis-
tribution for j = 1, . . . ,M and m= 2, . . . ,M .
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(f) Sample pi|Yobs,Ymis,(g) from its full conditional Dirichlet distribu-
tion.
Given the full set of observations for each subject (Yobsi ,Y
mis
i ), which we
have after step (a) of each iteration, we easily sample the model parameters
[steps (b)–(e) in the algorithm] associated with each row j of the transi-
tion matrix by gathering all the observations {Yit ∈ Y(i,1:(T−1)) :Yit = j},
and then treating the subsequent observations, Y(i,t+1) ∈ (1,2, . . . ,M), as
draws from a multinomial distribution with probability distributions given
in Equation (3), and we do this for rows j = 1, . . . ,M .
A.2. Fitting the HMM. The priors for the HMM are the same as they
are for the Markov model, except we replace M with S in Equations (7)–
(10), and we add the prior distributions for the parameters in the conditional
distributions, Ps ∼Dirichlet(1), for s= 1, . . . , S.
The HMM fit requires a similar, but slightly different Metropolis-within-
Gibbs MCMC algorithm from that of the Markov model. We follow Scott
(2002) and, in each iteration of the MCMC algorithm, use a forward-backward
recursion to evaluate the likelihood, sample the hidden states given the pa-
rameters, and then sample the parameters given the hidden states. The de-
tails are as follows:
1. First, initialize all model parameters. For the HMM, we initialize the pa-
rameters in a specific way so as to avoid the label-switching problem that
is common to fitting HMMs, and can be triggered by widely dispersed
starting points. First, we fit the HMM with S hidden states using the EM
algorithm, without incorporating covariates and with complete pooling
across subjects. We then set the values of β
(0)
rs to zero, and set the values
of µ
(0)
rs to the values such that, if all the N random intercepts α
(0)
irs, for
i= 1, . . . ,N , were set to equal µ
(0)
rs , the model would have the same exact
transition probabilities as MLE transition probabilities estimated from
the EM algorithm. This usually ensures that each chain in a multichain
MCMC algorithm converges to the same mode of the posterior distribu-
tion, which has S! symmetric modes corresponding to the permutations
of the state labels.
2. For g = 1, . . . ,G,
(a) Sample the vector Hi|Y
obs
i ,β,αi,P,pi from it’s full conditional dis-
tribution using the forward-backward recursion as described in detail
in Scott (2002), for i= 1, . . . ,N .
(b) Sample β, α, µ and σ given H just as they are sampled in steps (b)–
(e) in the Markov model, except replace the indices j and m with
r and s, respectively, for r = 1, . . . , S and s = 2, . . . , S, and replace
(Yobs,Ymis) with H.
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(c) Sample P|H,Yobs from its full conditional distribution.
(d) Sample pi|H1 from its full conditional Dirichlet distribution, where
H1 denotes the length-N vector of hidden states at time t= 1.
Data Files Included in the supplementary materials are two data files.
The first file, “y.csv,” contains the ordinal drink counts for each subject
on each day, and has N = 240 rows and T = 168 columns. The second file,
“x.csv,” contains the covariates used to fit our models, and contains sex,
treatment and prior drinking behavior for each subject.
SUPPLEMENTARY MATERIAL
Data Files (DOI: 10.1214/09-AOAS282SUPP; .zip). Included in the sup-
plementary materials are two data files. The first file, “y.csv,” contains the
ordinal drink counts for each subject on each day, and has N = 240 rows
and T = 168 columns. The second file, “x.csv,” contains the covariates used
to fit our models, and contains sex, treatment and prior drinking behavior
for each subject.
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